MicroPhage
Longmont
About MicroPhage
MicroPhage, Inc., a platform diagnostic technology company, develops medical diagnostics for bacterial identification and antibiotic susceptibility/resistance testing. Its products include methicillin-susceptible Staphylococcus aureus (MSSA)/methicillin-resistant Staphylococcus aureus (MRSA) blood culture tests, MRSA screening tests, and MRSA/MSSA screening tests. The company was founded in 2002 and is based in Longmont, Colorado.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.5M
- Last round: Debt Financing (Oct 2011)
- Website: microphage.com
- Phone: +1 303-652-5200
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Canonical: https://fsome.com/organization/microphage-3119833 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.